Vancomycin Therapeutic Drug Monitoring
- 1 May 1993
- journal article
- research article
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 27 (5) , 594-598
- https://doi.org/10.1177/106002809302700514
Abstract
OBJECTIVE: To review the literature and assess the validity of obtaining vancomycin serum drug concentrations in patients. DATA SOURCES: A MEDLINE search of the English literature and a bibliographic review of articles pertaining to vancomycin serum concentrations, their use, and the rationale of cited therapeutic ranges. STUDY SELECTION AND DATA EXTRACTION: Studies pertaining to the use of vancomycin concentrations in the clinical setting, methods for predicting these concentrations, and studies that reported efficacy or toxicity associated with vancomycin use and possible correlation of serum concentrations. DATA SYNTHESIS: The usefulness of vancomycin serum concentrations, the determination of a therapeutic range of values, and their correlation to antibacterial efficacy and drug toxicity in the clinical setting are controversial. Old reports of toxicities need to be critically examined due to lack of information and the actual frequency of toxic reactions. The efficacy of vancomycin's antibacterial effect and its correlation with reported therapeutic ranges may advocate obtaining a vancomycin trough concentration in certain groups of patients. CONCLUSIONS: Determination of serum vancomycin concentrations in the clinical setting and their usefulness in patient care is questionable and unnecessary in the majority of patients.Keywords
This publication has 41 references indexed in Scilit:
- Nephrotoxicity associated with vancomycin-aminoglycoside therapy in four childrenThe Journal of Pediatrics, 1984
- Pharmacokinetics of Vancomycin in Normal Subjects and in Patients with Reduced Renal FunctionClinical Infectious Diseases, 1981
- The Antibacterial Action of VancomycinClinical Infectious Diseases, 1981
- Introduction to VancomycinClinical Infectious Diseases, 1981
- Pharmacokinetics of Vancomycin in Normal Subjects and in Patients with Reduced Renal FunctionClinical Infectious Diseases, 1981
- The Antibacterial Action of VancomycinClinical Infectious Diseases, 1981
- Introduction to VancomycinClinical Infectious Diseases, 1981
- Single‐Dose Kinetics of Intravenous VancomycinThe Journal of Clinical Pharmacology, 1980
- Clinical pharmacology and efficacy of vancomycin in pediatric patientsThe Journal of Pediatrics, 1980
- Prevention of Staphylococcal shunt infections by continuous vancomycin prophylaxisThe Lancet Healthy Longevity, 1971